Register today to take advantage of early bird pricing!
2024 Speaker Line-up
Julie Yoo
Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system.
Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access. Julie led product management, engineering, and sales and marketing for the company, and helped scale the business to reach 20M patients and over 225,000 healthcare providers across the U.S.
Julie was previously VP of Product at Generation Health, and was with the company from its inception through acquisition by CVS Health. Julie was also a Product Manager at Knome, the world's first whole genome sequencing service for private individuals. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle.
Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health.
Julie serves on a number of portfolio company boards, including AKASA, Bayesian Health, Firefly Health, Patina, Ribbon Health, Season Health, Sprinter Health, Tomorrow Health, Turquoise Health and Zus Health.
Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system.
Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access. Julie led product management, engineering, and sales and marketing for the company, and helped scale the business to reach 20M patients and over 225,000 healthcare providers across the U.S.
Julie was previously VP of Product at Generation Health, and was with the company from its inception through acquisition by CVS Health. Julie was also a Product Manager at Knome, the world's first whole genome sequencing service for private individuals. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle.
Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health.
Julie serves on a number of portfolio company boards, including AKASA, Bayesian Health, Firefly Health, Patina, Ribbon Health, Season Health, Sprinter Health, Tomorrow Health, Turquoise Health and Zus Health.
Heather O'Sullivan, MS, RN, AGNP
Heather O’Sullivan, MS, RN, AGNP, a leading expert in health care innovation and transformation, is President of Healthcare at Home at Mass General Brigham, where she leads operations of one of the country’s largest Home Hospitals.
With three decades of experience, Heather has unrivaled knowledge and insight on strategic innovation and rapid growth initiatives in clinical and payer spaces. Under her leadership, Mass General Brigham’s patients receive the same, best-in-class acute-level hospital services as those at the system’s nationally recognized medical centers — but from the comfort of their homes. Since January of 2022, MGB Home Hospital has cared for over 3,000 patients, including over 1,500 in 2023 alone. The team’s patient-centered approach, technological investments and strategic partnerships have lowered mortality rates, reduced readmission rates and decreased patients’ length of stay while reducing strain on hospitals. Most recently, Heather spearheaded a novel, cross-sector partnership with Best Buy Health that will define logistics solutions to optimize care delivery across the continuum of needs in the home setting and create opportunities to enable the next generation of Healthcare at Home workforce. These accomplishments contributed to Heather being recognized as a Top Innovator of the Year by Modern Healthcare in 2023.
Within the $18 billion not-for-profit health system, Heather also manages a dynamic portfolio of affiliated at-home clinical offerings, including Palliative Care, Emergency services, and a Mobile Integrated Health fleet.
Recognized as a pioneer in defining the future of complex care-at-home, Heather's expertise spans clinical and infrastructure operations, fiscal oversight, and M&A experiences. Prior to joining Mass General Brigham, Heather served as the Executive Vice President and Chief Clinical Innovation Officer of Kindred at Home, the largest home health and hospice services provider in the United States, during the period leading up to the Humana acquisition. Additionally, she previously served as Chief Clinical Officer at naviHealth and began her leadership journey at UnitedHealth Group, where she directed medical and clinical operations for full-risk health plans in the post-acute and community settings.
Earlier in her career, as a Registered Nurse and Nurse Practitioner, Heather specialized in caring for patients with HIV/AIDS as well as complex Geriatric patients in Skilled Long-term Care Facilities. She holds a Master of Science degree from Simmons University in Boston and a Bachelor of Science from the Medical University of South Carolina. She currently serves on the boards of Nantucket Cottage Hospital and South Cove Manor and is a member of the corporate advisory council of American Organization of Nurse Leaders’ (AONL) Foundation Board of Directors as well as the Massachusetts Hospital Association Continuum of Care Committee. She is a guest lecturer at Harvard Medical School and the Harvard T.H. Chan School of Public Health and holds a professor appointment at Mass General Hospital Institute of Health Professions, where she also serves on the School of Nursing Advisory Board.
Heather O’Sullivan, MS, RN, AGNP, a leading expert in health care innovation and transformation, is President of Healthcare at Home at Mass General Brigham, where she leads operations of one of the country’s largest Home Hospitals.
With three decades of experience, Heather has unrivaled knowledge and insight on strategic innovation and rapid growth initiatives in clinical and payer spaces. Under her leadership, Mass General Brigham’s patients receive the same, best-in-class acute-level hospital services as those at the system’s nationally recognized medical centers — but from the comfort of their homes. Since January of 2022, MGB Home Hospital has cared for over 3,000 patients, including over 1,500 in 2023 alone. The team’s patient-centered approach, technological investments and strategic partnerships have lowered mortality rates, reduced readmission rates and decreased patients’ length of stay while reducing strain on hospitals. Most recently, Heather spearheaded a novel, cross-sector partnership with Best Buy Health that will define logistics solutions to optimize care delivery across the continuum of needs in the home setting and create opportunities to enable the next generation of Healthcare at Home workforce. These accomplishments contributed to Heather being recognized as a Top Innovator of the Year by Modern Healthcare in 2023.
Within the $18 billion not-for-profit health system, Heather also manages a dynamic portfolio of affiliated at-home clinical offerings, including Palliative Care, Emergency services, and a Mobile Integrated Health fleet.
Recognized as a pioneer in defining the future of complex care-at-home, Heather's expertise spans clinical and infrastructure operations, fiscal oversight, and M&A experiences. Prior to joining Mass General Brigham, Heather served as the Executive Vice President and Chief Clinical Innovation Officer of Kindred at Home, the largest home health and hospice services provider in the United States, during the period leading up to the Humana acquisition. Additionally, she previously served as Chief Clinical Officer at naviHealth and began her leadership journey at UnitedHealth Group, where she directed medical and clinical operations for full-risk health plans in the post-acute and community settings.
Earlier in her career, as a Registered Nurse and Nurse Practitioner, Heather specialized in caring for patients with HIV/AIDS as well as complex Geriatric patients in Skilled Long-term Care Facilities. She holds a Master of Science degree from Simmons University in Boston and a Bachelor of Science from the Medical University of South Carolina. She currently serves on the boards of Nantucket Cottage Hospital and South Cove Manor and is a member of the corporate advisory council of American Organization of Nurse Leaders’ (AONL) Foundation Board of Directors as well as the Massachusetts Hospital Association Continuum of Care Committee. She is a guest lecturer at Harvard Medical School and the Harvard T.H. Chan School of Public Health and holds a professor appointment at Mass General Hospital Institute of Health Professions, where she also serves on the School of Nursing Advisory Board.
James N. Weinstein, MS, D.O.
Dr. James N. Weinstein joined Microsoft in July 2018 as Senior Vice President, Microsoft Health, leading strategy, and innovation. Today, Jim leads health access and health equity, globally. Jim is the immediate past Chief Executive Officer and President of Dartmouth Health. Prior to being CEO/President, he was President of the Dartmouth physician group and was the inaugural Director of the Dartmouth Institute, home of the Dartmouth Atlas.
He created the first, value-based, population health, operating model locally and nationally, grounded in, the quadruple aim. He created a joint venture with Harvard-Pilgrim to create a provider/payer “health plan” for Northern New England. He worked with Congress during three Presidential administrations. He helped lead ACO population-based strategies and led the national efforts in Patient Reported Outcome Measures (PROM’s) and Health Equity for National Academies. In 2010, Epic EHR, adopted his real-time PROM’s. During his time as Director of TDI, Dr. Weinstein co-founded, with then Dartmouth College President Jim Yong Kim (past President of the World Bank), the Master of “Health Care Delivery Science” (MHCDS) program, the first hybrid residential and distance learning degree program at Dartmouth. He started the first multi-state telehealth program, across 12 states covering over 240 ICU beds and the first patient remote monitoring system, Imagincare.
Dr. Weinstein held the distinguished Peggy Y. Thomson Chair in the Evaluative Clinical Sciences while at Dartmouth. He is a member of the National Academy of Medicine (NAM) and served on the organization’s Board for Population Health and Public Health Practice. He served as Chair of the first NAM Committee; Community Based Solutions to Promote Health Equity, which published its’ report, “Communities in Action: Pathways to Health Equity”, 2017. He serves on several Boards of Trustees: Max Planck Institute for Neuroscience; Intermountain Health System; Centene Health, Disparity Advisory Board; Charles Drew Medical School Advisory Board on Inequities; ARMI board, Advanced Regenerative Manufacturing (DOD funded). ARMI uses 3D technology to print human organoids.
Dr. Weinstein worked for several Presidential administrations and was appointed, by President Obama, to the Special Medical Advisory Group of the VA, providing advice to three Secretary and Under Secretary for Veterans Health. While at Microsoft he participated in Operation Warp speed for Covid and continues to work on Rural Health with the current administration. In 2015, Dr. Weinstein was awarded the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations. He is the 2017 recipient of the prestigious, American Hospital Association’s, Justin Ford Kimball Innovator’s Award. He has been named one of “The 100 Most Influential People in Healthcare” by Modern Healthcare magazine and top 50 “Physician Leaders to Know” by Becker’s Hospital Review. He holds a Clinical Professorship in the Northwestern Kellogg Business School, Public & Private Interface initiative, where he teaches, “CEO Playbook for Health System Success”. He participates annually at the Harvard Business school facilitating the case study about the center he created at Dartmouth for Spine Care. He started the center, while at the University of Iowa where he was an endowed professor.
Today, he serves as a distinguished professor, at TUCK, Dartmouth Business school. Dr. Weinstein was the Executive Director and founding member, National High Value Healthcare Collaborative (HVHC;70 million patients, 70,000 physicians) in all 50 states. As a spine surgeon, Dr. Weinstein Jim Weinstein developed the classification system by which cancers of the spine are treated. He is the recipient of three Kappa Delta awards (top Orthopedic research award); 1) Knee Joint Kinematics; 2) Understanding pain mechanisms seen in back pain patients and, 3) SPORT (Spine Outcomes Research Trial), the largest funded NIH clinical trial. He served as, Editor-in-Chief, SPINE, for 28 years. He received more than $70 million in federal research funding and has published more than 345 peer reviewed papers. He is a leader in advancing "informed choice". His most recent book, “Unraveled: Prescriptions to Repair a Broken Health Care System”, was published in February 2016. It serves as a road map for many of the changes needed in Health Care and has been part of his work at Microsoft. Over the years he has appeared on CBS, ABC, NPR, the Washington Post, NYTs, and others. He recently proposed the “Federal Reserve for Health” JAMA, Health Forum 2021. He is a contributor to the latest book on AI; Peter Lee et al; The AI revolution in Medicine, Chat GPT4 and beyond, March 2023.
Dr. James N. Weinstein joined Microsoft in July 2018 as Senior Vice President, Microsoft Health, leading strategy, and innovation. Today, Jim leads health access and health equity, globally. Jim is the immediate past Chief Executive Officer and President of Dartmouth Health. Prior to being CEO/President, he was President of the Dartmouth physician group and was the inaugural Director of the Dartmouth Institute, home of the Dartmouth Atlas.
He created the first, value-based, population health, operating model locally and nationally, grounded in, the quadruple aim. He created a joint venture with Harvard-Pilgrim to create a provider/payer “health plan” for Northern New England. He worked with Congress during three Presidential administrations. He helped lead ACO population-based strategies and led the national efforts in Patient Reported Outcome Measures (PROM’s) and Health Equity for National Academies. In 2010, Epic EHR, adopted his real-time PROM’s. During his time as Director of TDI, Dr. Weinstein co-founded, with then Dartmouth College President Jim Yong Kim (past President of the World Bank), the Master of “Health Care Delivery Science” (MHCDS) program, the first hybrid residential and distance learning degree program at Dartmouth. He started the first multi-state telehealth program, across 12 states covering over 240 ICU beds and the first patient remote monitoring system, Imagincare.
Dr. Weinstein held the distinguished Peggy Y. Thomson Chair in the Evaluative Clinical Sciences while at Dartmouth. He is a member of the National Academy of Medicine (NAM) and served on the organization’s Board for Population Health and Public Health Practice. He served as Chair of the first NAM Committee; Community Based Solutions to Promote Health Equity, which published its’ report, “Communities in Action: Pathways to Health Equity”, 2017. He serves on several Boards of Trustees: Max Planck Institute for Neuroscience; Intermountain Health System; Centene Health, Disparity Advisory Board; Charles Drew Medical School Advisory Board on Inequities; ARMI board, Advanced Regenerative Manufacturing (DOD funded). ARMI uses 3D technology to print human organoids.
Dr. Weinstein worked for several Presidential administrations and was appointed, by President Obama, to the Special Medical Advisory Group of the VA, providing advice to three Secretary and Under Secretary for Veterans Health. While at Microsoft he participated in Operation Warp speed for Covid and continues to work on Rural Health with the current administration. In 2015, Dr. Weinstein was awarded the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations. He is the 2017 recipient of the prestigious, American Hospital Association’s, Justin Ford Kimball Innovator’s Award. He has been named one of “The 100 Most Influential People in Healthcare” by Modern Healthcare magazine and top 50 “Physician Leaders to Know” by Becker’s Hospital Review. He holds a Clinical Professorship in the Northwestern Kellogg Business School, Public & Private Interface initiative, where he teaches, “CEO Playbook for Health System Success”. He participates annually at the Harvard Business school facilitating the case study about the center he created at Dartmouth for Spine Care. He started the center, while at the University of Iowa where he was an endowed professor.
Today, he serves as a distinguished professor, at TUCK, Dartmouth Business school. Dr. Weinstein was the Executive Director and founding member, National High Value Healthcare Collaborative (HVHC;70 million patients, 70,000 physicians) in all 50 states. As a spine surgeon, Dr. Weinstein Jim Weinstein developed the classification system by which cancers of the spine are treated. He is the recipient of three Kappa Delta awards (top Orthopedic research award); 1) Knee Joint Kinematics; 2) Understanding pain mechanisms seen in back pain patients and, 3) SPORT (Spine Outcomes Research Trial), the largest funded NIH clinical trial. He served as, Editor-in-Chief, SPINE, for 28 years. He received more than $70 million in federal research funding and has published more than 345 peer reviewed papers. He is a leader in advancing "informed choice". His most recent book, “Unraveled: Prescriptions to Repair a Broken Health Care System”, was published in February 2016. It serves as a road map for many of the changes needed in Health Care and has been part of his work at Microsoft. Over the years he has appeared on CBS, ABC, NPR, the Washington Post, NYTs, and others. He recently proposed the “Federal Reserve for Health” JAMA, Health Forum 2021. He is a contributor to the latest book on AI; Peter Lee et al; The AI revolution in Medicine, Chat GPT4 and beyond, March 2023.
Ateev Mehrotra, M.D., MPH
Ateev Mehrotra, M.D., M.P.H. is the Walter H. Annenberg Distinguished Professor and Chair of the Department of Health Services, Policy, and Practice at the Brown School of Public Health
Dr. Mehrotra’s research focuses on delivery innovations and their impact on access, quality, and spending. Dr. Mehrotra has led seminal work evaluating the impact of telemedicine on costs and quality. He has published over three hundred peer reviewed papers in the field of health services and health policy. He previously served as professor of health care policy at Harvard Medical School, while also working as a hospitalist at the Beth Israel Deaconess Medical Center in Boston.
Dr. Mehrotra received a B.S. from MIT, an M.D. from the University of California, San Francisco, and completed his residency in internal medicine and pediatrics at the Massachusetts General Hospital and Children’s Hospital of Boston. He also holds an MPH from the University of California, Berkeley, and a Master of Science in epidemiology from Harvard’s T.H. Chan School of Public Health.
Ateev Mehrotra, M.D., M.P.H. is the Walter H. Annenberg Distinguished Professor and Chair of the Department of Health Services, Policy, and Practice at the Brown School of Public Health
Dr. Mehrotra’s research focuses on delivery innovations and their impact on access, quality, and spending. Dr. Mehrotra has led seminal work evaluating the impact of telemedicine on costs and quality. He has published over three hundred peer reviewed papers in the field of health services and health policy. He previously served as professor of health care policy at Harvard Medical School, while also working as a hospitalist at the Beth Israel Deaconess Medical Center in Boston.
Dr. Mehrotra received a B.S. from MIT, an M.D. from the University of California, San Francisco, and completed his residency in internal medicine and pediatrics at the Massachusetts General Hospital and Children’s Hospital of Boston. He also holds an MPH from the University of California, Berkeley, and a Master of Science in epidemiology from Harvard’s T.H. Chan School of Public Health.
Alison Holliday, MD, MPH
Alison Holliday, MD MPH is a Geriatrician and national leader in health care innovation for older adults.
She is the Chair of the American Geriatrics Society Telehealth Committee, through which she leads work around the country on telehealth policy and advocacy. She is the National Medical Director of Geriatrics at Devoted Health, where she develops clinical strategies to empower older adults to age well in their homes. She also continues to care for patients via telehealth.
Dr. Holliday has a background in health system leadership, population health management, research, medical education, and quality and safety. She earned her undergraduate degree at Stanford University, graduating Phi Beta Kappa with distinction in Statistics, her master’s degree in public health at the London School of Hygiene and Tropical Medicine, and her medical degree at Harvard Medical School, where she was a Harvard Foster Scholar. She completed residency in Internal Medicine at Brigham and Women's Hospital and fellowship in Geriatric Medicine through the Harvard Geriatrics Fellowship.
She has been recognized through numerous awards and honors for her leadership and innovation in the field of Geriatrics, as well as quality improvement, research, education, and health policy. She continues to serve as a guest lecturer at Harvard Medical School and within the Harvard Geriatrics department.
Alison Holliday, MD MPH is a Geriatrician and national leader in health care innovation for older adults.
She is the Chair of the American Geriatrics Society Telehealth Committee, through which she leads work around the country on telehealth policy and advocacy. She is the National Medical Director of Geriatrics at Devoted Health, where she develops clinical strategies to empower older adults to age well in their homes. She also continues to care for patients via telehealth.
Dr. Holliday has a background in health system leadership, population health management, research, medical education, and quality and safety. She earned her undergraduate degree at Stanford University, graduating Phi Beta Kappa with distinction in Statistics, her master’s degree in public health at the London School of Hygiene and Tropical Medicine, and her medical degree at Harvard Medical School, where she was a Harvard Foster Scholar. She completed residency in Internal Medicine at Brigham and Women's Hospital and fellowship in Geriatric Medicine through the Harvard Geriatrics Fellowship.
She has been recognized through numerous awards and honors for her leadership and innovation in the field of Geriatrics, as well as quality improvement, research, education, and health policy. She continues to serve as a guest lecturer at Harvard Medical School and within the Harvard Geriatrics department.
Curtis Cole, M.D
Jonathan St. George, MD
Stay tuned! Additional Speakers to Be Announced
Register today to take advantage of early bird pricing!
